ACELYRIN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.24 USD | 0.00% |
|
-12.03% | -43.16% |
| Apr. 05 | North American Morning Briefing : Investors on Edge as High-Stakes Jobs Report Awaited | DJ |
| Mar. 28 | Acelyrin, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Acelyrin, Inc.
45bebf4d411.qpFAsBQ5vVXwd2dNYRZKrcBFtdXKSxZh6wgvx_rWKqQ.49oP9yVO3zioFVQAB1MI9bov_JagDkIRpz94l760aZ3G9BmCeVyNYKAkCA~149ebad189e575212898507877414b65
Upcoming events on Acelyrin, Inc.
Past events on Acelyrin, Inc.
| 2024-03-28 04:05 pm | Q4 2023 Earnings Release |
| 2024-03-20 08:30 am | Lonigutamab Phase 1/2 Proof of concept Data in Thyroid Eye Disease Call |
| 2024-03-10 | Investor Meeting |
| 2024-02-14 | Investor Meeting |
| 2023-11-16 04:00 am | Jefferies London Healthcare Conference |
| 2023-11-07 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-07 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-13 11:30 am | Morgan Stanley Global Healthcare Conference |
| 2023-09-11 05:30 pm | Izokibep Phase 2b/3 Trial Results Call |
| 2023-08-14 04:30 pm | Q2 2023 Earnings Call |
| 2023-08-14 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-15 04:05 pm | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 -416 - | -416 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -422 -418 -0.93% | -381 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -382 -386 1.23% | -376 |
|
Net income Million USD | Released Forecast Spread | -64,8 | -382 -386 1.23% | -376 |
|
EPS USD | Released Forecast Spread | -21,1 | -5,43 -7,14 23.92% | -3,74 |
| Announcement Date | 13/04/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -99,1 | -101 | -103 | -105 | ||||
|
EBIT Million USD | Released Forecast Spread | -42,7 -59,8 28.64% | -94,4 -46,1 -104.82% | -105 -99,3 -5.9% | -96,0 | -99,8 | -102 | -108 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -26,0 -60,7 57.13% | -83,9 -41,7 -101.42% | -95,2 -95,0 -0.2% | -95,1 | -98,5 | -102 | -107 | |
|
Net income Million USD | Released Forecast Spread | -176 | -26,0 -60,7 57.13% | -83,9 -41,7 -101.42% | -95,2 -95,0 -0.2% | -95,1 | -98,5 | -102 | -107 |
|
EPS USD | Released Forecast Spread | -8,61 | -0,40 -0,85 52.66% | -0,87 -0,47 -86.7% | -0,75 -0,99 23.93% | -0,93 | -0,94 | -0,92 | -0,93 |
| Announcement Date | 15/06/23 | 14/08/23 | 07/11/23 | 28/03/24 | - | - | - | - |
More events
Past sector events for Acelyrin, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SLRN Stock
- Calendar Acelyrin, Inc.
